Nursing home group Korian has continued its consolidation of mental health by acquiring an Italian group with €22.5m revenues. Meanwhile, a joint venture in the Netherlands between providers Parnassia and Altrecht is expanding.
Investors in the US are pouring money into dermatology, while EU markets remain far quieter. To find out where and why deals are – and aren’t - happening, we round up the latest news from the sector in Europe, including the UK dermatology consultant-led business Dermatology Partnership, Sweden’s leading dermatology provider Diagnostiskt Centrum Hud, and Dermatologikum Hamburg in Germany.
Private equity firm Cardinal Capital Group has bought Ashdale Care, which provides specialist therapeutic care for children with complex behavioural needs in Ireland.
As expected, M&A deal flow slowed through August as bankers and executives headed out on summer vacations. HBI has caught up with the mid-to-small-cap deals you may have missed; featuring hospitals, ophthalmology, and homecare.
GCC investment firm Foundation Holdings has bought a majority stake in Saudi primary care business Shifa Al Munthaza Polyclinic (SMP) and has plans to list it in the next two years. HBI speaks to CEO Abishek Sharma to find out about its growth plans.
Brazilian hospital group Rede D'Or has pulled back on its attempt to takeover imaging group Alliar after it became clear it could not take control. However, large lab group Fleury has now also thrown its hat into the ring for a stake.
Hungarian billionaire Sándor Csányi has bought out the remaining 25% equity of Buda Health Center, Hungary's second-largest private acute care operator by revenue, from its founder. The new ownership is set on completing the construction of a new inpatient block.
Slovenian private equity firm Alfi PE is creating a double-digit revenue imaging platform with the acquisition of the country's two largest for-profit imaging operators, managing director Tone Pekolj tells HBI.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.